@FierceBiotech: Check out this report on the pulse of biotech IT in Boston by @RyanMFierce. Report | Follow @FierceBiotech
@JohnCFierce: The Spanish crisis getting worse, Italian economy shrinking, U.K. back in recession. U.S. economy slows. Interesting times. Article | Follow @JohnCFierce
@RyanMFierce: Novo Nordisk plans to grow its U.S. workforce 15% in 2012. Nice change from usual drumbeat of pharma layoffs. Release | Follow @RyanMFierce
> Merck's ($MRK) research and development budget dropped 14% in the first quarter as profits soared 64%. Release | Article
> GlaxoSmithKline ($GSK) has agreed to fund two-thirds of the £18 million ($29.2 million) cost of a new laboratory at the University of Nottingham, of which GSK CEO Andrew Witty is a graduate. Report
> The CRO industry group ACRO wants faster action on efforts to modernize clinical trials. Report
> Novartis ($NVS) has won FDA approval of its kidney cancer drug Afinitor for combating kidney tumors called renal angiomyolipomas and tuberous sclerosis complex. News
Pharma News
@FiercePharma: Drama at J&J annual meeting: One investor hopes new CEO will "lead us back" to being happy when $JNJ's in the news--AP. Story | Follow @FiercePharma
> Boosted by Januvia, Merck bests expectations by a penny. News
> Amgen gets a no from the FDA on extended use of Xgeva. Story
> Bristol-Myers Squibb confirms it's a target of bribery probe. Article
> Jazz Pharmaceuticals announces another deal. More
Medical Devices News
@FierceMedDev: FDA panel gives Cameron Health good news on implantable ICD. News | Follow @FierceMedDev
> High-impact sports reduce life span of artificial hips. Report
> Covidien sees strong quarter on device sales, emerging markets growth. Article
> FDA panel gives Cameron Health good news on implantable ICD. Story
And Finally… Array BioPharma ($ARRY) has tapped former Hospira ($HSP) executive Ron Squarer to be its CEO. Release